SenesTech, Inc. (NASDAQ:SNES – Get Free Report) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 48,100 shares, a decline of 12.4% from the December 31st total of 54,900 shares. Approximately 4.8% of the company’s shares are sold short. Based on an average trading volume of 121,200 shares, the short-interest ratio is presently 0.4 days.
SenesTech Price Performance
Shares of SenesTech stock opened at $2.82 on Monday. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05. The company has a 50-day moving average of $2.94 and a 200 day moving average of $3.10. SenesTech has a 1 year low of $1.90 and a 1 year high of $13.30.
Wall Street Analyst Weigh In
SNES has been the subject of several research reports. StockNews.com initiated coverage on shares of SenesTech in a report on Tuesday, January 28th. They issued a “sell” rating for the company. HC Wainwright upped their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Underrated Robotics Stocks Poised for Major Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Reshoring Riches: Investing in Made in America 2.0
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 REITs to Watch as Interest Rates Keep Falling
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.